Doctor Federico Felizzi
Novartis, Basel (Switzerland)
Indirect treatment comparison of ARNI vs SGLT2i in heart failure with reduced ejection fraction: a reconciliation of previous network meta-analyses
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: Chronic heart failure - pharmacotherapy 3
